Robert J. Terifay, SVP Commercial at REGENERON PHARMACEUTICALS INC (REGN), sold 20,000 shares at $175.09 ($3.5M) on 2012-11-23, disclosed to the SEC on 2012-11-26.
Open-market sale of $3.5M REGN by SVP Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $173.83 | 1,932 | $336K | 9.6% |
| 2 | $173.83 | 8,323 | $1.4M | 41.5% |
| 3 | $173.90 | 1,000 | $174K | 5.0% |
| 4 | $174.33 | 6,700 | $1.2M | 33.5% |
| 5 | $175.09 | 2,045 | $358K | 10.3% |
| Total | $174.13 avg | 20,000 |
| $3.5M |
| 100% |
| Filing → |
| REGN | SELL | 2015-03-18 | $5.0M | — | Filing → |
| REGN | SELL | 2015-02-25 | $4.7M | — | Filing → |
| REGN | SELL | 2014-11-19 | $9.1M | — | Filing → |